Cargando…
Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645121/ http://dx.doi.org/10.1186/2051-1426-3-S2-P178 |
_version_ | 1782400766909087744 |
---|---|
author | Velcheti, Vamsidhar Pennell, Nathan A Rakshit, Sagar Stevenson, James Shapiro, Marc Almeida, Francisco A Gurajala, Ram Schalper, Kurt Alex Saunthararajah, Yogen |
author_facet | Velcheti, Vamsidhar Pennell, Nathan A Rakshit, Sagar Stevenson, James Shapiro, Marc Almeida, Francisco A Gurajala, Ram Schalper, Kurt Alex Saunthararajah, Yogen |
author_sort | Velcheti, Vamsidhar |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4645121 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46451212015-11-20 Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer Velcheti, Vamsidhar Pennell, Nathan A Rakshit, Sagar Stevenson, James Shapiro, Marc Almeida, Francisco A Gurajala, Ram Schalper, Kurt Alex Saunthararajah, Yogen J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4645121/ http://dx.doi.org/10.1186/2051-1426-3-S2-P178 Text en Copyright © 2015 Velcheti et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Velcheti, Vamsidhar Pennell, Nathan A Rakshit, Sagar Stevenson, James Shapiro, Marc Almeida, Francisco A Gurajala, Ram Schalper, Kurt Alex Saunthararajah, Yogen Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer |
title | Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer |
title_full | Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer |
title_fullStr | Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer |
title_full_unstemmed | Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer |
title_short | Novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer |
title_sort | novel pharmacologic approach to enhance the epigenetic and immune priming effect of decitabine in patients with advanced non-small cell lung cancer |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645121/ http://dx.doi.org/10.1186/2051-1426-3-S2-P178 |
work_keys_str_mv | AT velchetivamsidhar novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer AT pennellnathana novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer AT rakshitsagar novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer AT stevensonjames novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer AT shapiromarc novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer AT almeidafranciscoa novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer AT gurajalaram novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer AT schalperkurtalex novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer AT saunthararajahyogen novelpharmacologicapproachtoenhancetheepigeneticandimmuneprimingeffectofdecitabineinpatientswithadvancednonsmallcelllungcancer |